Revise Phase III protocol: CDSCO Panel Tells Mankind Over Roflumilast Cream Dr. Divya Colin27 April 2025 5:45 PM ISTNew Delhi: Responding to the proposal presented by Mankind Pharmaceutical to manufacture and market selective phosphodiesterase-4 inhibitor...
Oral Roflumilast Shows Promise in Treating Recurrent Aphthous Stomatitis: Multicenter Study Highlights Efficacy and Safety Medha Baranwal26 Dec 2024 8:15 PM ISTSpain: A multicenter observational study has highlighted the potential of oral roflumilast, a phosphodiesterase-4 (PDE4) inhibitor, as an effective...
Roflumilast may effectively reduce symptoms and flare-ups in recurrent aphthous stomatitis, suggests study Dr. Shravani Dali26 Nov 2024 2:00 AM ISTRoflumilast may effectively reduce symptoms and flare-ups in recurrent aphthous stomatitis, suggests study published in the International Journal of...
Oral roflumilast safe and effective therapy for patients with recurrent aphthous stomatitis: Study Dr. Shravani Dali16 Oct 2024 8:00 PM ISTA study published in the International Journal of Dermatology suggests that oral roflumilast is a safe and effective therapy for patients with...
Roflumilast Foam Potential Game-Changer in Seborrheic Dermatitis Treatment Dr.Niharika Harsha B4 Feb 2024 10:00 PM ISTIn a remarkable breakthrough, a novel topical treatment has demonstrated unprecedented efficacy in tackling seborrheic dermatitis (SD), a chronic skin...
Roflumilast topical foam receives FDA approval for treating seborrheic dermatitis Dr. Kamal Kant Kohli18 Dec 2023 8:00 AM ISTUSA: Roflumilast topical foam, 0.3% has received approval from the US Food and Drug Administration (FDA), for the treatment of seborrheic dermatitis...
Medical Bulletin 21/September/2023 Isra Zaman21 Sept 2023 3:15 PM ISTHere are the top medical news of the day:Excess screen in children linked to delayed development : Study A new study conducted in Japan highlights...
Roflumilast Foam Found Safe and Effective for Seborrheic Dermatitis Treatment: JAMA Dr. Mahalakshmi Sivashankaran12 May 2023 10:00 AM ISTA recent clinical trial published in JAMA: Dermatology has shown promising results for roflumilast foam as a nonsteroidal topical treatment option for...
Roflumilast cream effective for treating plaque psoriasis: JAMA Dr. Kamal Kant Kohli26 Sept 2022 7:30 PM ISTUSA: According to a study published in JAMA Network, roflumilast cream was effective in treating plaque psoriasis in patients after 8 weeks of...
Roflumilast foam useful in patients with moderate to severe seborrheic dermatitis, reveals phase 3 trial Dr. Kamal Kant Kohli12 Jun 2022 7:30 PM ISTWESTLAKE VILLAGE, Calif: Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a late-stage biopharmaceutical company focused on developing meaningful...
Topical roflumilast improves chronic plaque psoriasis, finds new research Dr. Kamal Kant Kohli18 July 2020 7:00 AM ISTResearchers at the Icahn School of Medicine report that roflumilast cream (ARQ-151), which contains a highly potent, selective phosphodiesterase-4...
